Medca Japan <9707.Q>-2008/09 parent results

July 14 (Reuters) -

MEDCA JAPAN CO LTD

PARENT-ONLY FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to Six months to

May 31, 2009 May 31, 2008 May 31, 2010 Nov 30, 2009

LATEST YEAR-AGO COMPANY COMPANY

RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 24.31 22.88 24.80 12.20

(+6.3 pct) (+11.5 pct) (+2.0%) (+0.5%)
Operating 264 mln 364 mln 800 mln 320 mln

(-27.6 pct) (-49.7 pct) (+202.9%) (+38.8%)
Recurring loss 280 mln loss 395 mln prft 280 mln prft 50 mln
Net loss 11.41 loss 11.41 prft 150 mln loss 10 mln
EPS loss Y154.42 loss Y203.07 prft Y2.03 loss Y0.14
Annual div nil nil nil
-Q2 div nil nil nil
-Q4 div nil nil nil

NOTE - Medca Japan Co Ltd is involved in clinical experiments.

If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.

For latest earnings estimates made by Toyo Keizai, please
double click on 9707.TK1.